National Academy of Agricultural Sciences (NAAS)
|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
In India, HBsAg prevalence among the general population ranges from 2 to 8%, which places India in an intermediate HBV endemicity zone. HBV is transmitted through several routes. The route that is important in health care setting is, exposure of health care personnel to HBV-positive blood or other body fluids while providing investigative & therapeutic care to HBV infected patients. It remains a significant risk in developing countries reflecting the higher prevalence of CHB, limited access to HBV vaccination and PEP and a lack of adherence to standard infection control precautions. To know the seroprevalence of HBV among pre-surgical patients. The present study was conducted between January 2015 and December 2015. Presurgical cases of all age groups, were included in the study. Serum was collected and HBsAg detection was done by immunochromatographic method. A total of 4977 cases (Males-43.46%; Females-56.54%) were screened for HBsAg with age ranging from 1 yr to 92 yrs years. More number of cases were from ophthalmology (1825/4977) followed by general surgery (1241/4977) and gynecology (1202/2814). In males 27.60% of cases were from >60yrs age group with 3.68% seropositivity. Whereas in females highest number of cases were from 21-30yrs age group (21.53%) with 2.97% of seropositivity. The overall seropositivity for HBsAg was 2.45%. But seropositivity was highest in >60yrs (3.03%) followed by in 31- 40 yrs age group (2.97%). The seropositivity among males was more (2.96%) when compared to females (2.06%). It concludeds 1. Seropositivity of HBsAg in pre surgical cases was 2.45%, 2. Seropositivity was more in males (2.96%) than in females (2.06%), 3. Seropositivity was highest in >60yrs (3.03%) followed by 31- 40 yrs age group (2.97%), 4. With 2.45% of seroprevalence among pre-surgical cases, routine pre-surgical screening is necessary to prevent occupational exposure to HCPs.
Citations |
 |
 |
 |
 |
